Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Winter storms, rain and snow wallopping Canada. Here’s where you’ll see it

December 14, 2025

GeeFi’s (GEE) Presale Reports Strong Momentum With 80% of Phase 2 Already Sold Out

December 14, 2025

I’m finally beginning to trust Microsoft’s handheld Xbox Allys

December 14, 2025

Evacuation alerts in Abbotsford, B.C. rescinded as floodwaters recede

December 14, 2025

GeeFi (GEE) Announces Upcoming DEX Focused on Smarter and User-Centric Trading

December 14, 2025
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Global BCG Vaccine Market to Showcase 5.47% CAGR Through 2034, Driven by Advancements and Global Tuberculosis Burden – Trends and Insights by Age Group, Application, Distribution Channel, and Region
Press Release

Global BCG Vaccine Market to Showcase 5.47% CAGR Through 2034, Driven by Advancements and Global Tuberculosis Burden – Trends and Insights by Age Group, Application, Distribution Channel, and Region

By News RoomMarch 11, 20243 Mins Read
Global BCG Vaccine Market to Showcase 5.47% CAGR Through 2034, Driven by Advancements and Global Tuberculosis Burden – Trends and Insights by Age Group, Application, Distribution Channel, and Region
Share
Facebook Twitter LinkedIn Pinterest Email
Global BCG Vaccine Market to Showcase 5.47% CAGR Through 2034, Driven by Advancements and Global Tuberculosis Burden – Trends and Insights by Age Group, Application, Distribution Channel, and Region

Dublin, March 11, 2024 (GLOBE NEWSWIRE) — The “Global BCG Vaccine Market by Age Group, Application, Distribution Channel, and By Region” report has been added to ResearchAndMarkets.com’s offering.

The global BCG vaccine market is set to witness substantial growth, expanding from USD 104.6 million in 2023 to USD 187.9 million by 2034, at a CAGR of 5.47% during the forecast period (2024-2034). This significant market growth is attributed to the increasing prevalence of tuberculosis worldwide, the expansion of immunization programs, and a growing awareness of potential off-label uses. Technological advancements, government support, international initiatives, and industry collaborations are also key factors fueling market expansion.

In light of the World Health Organization’s reports on the ongoing tuberculosis epidemic, there is a heightened critical need for BCG vaccination, especially among the pediatric population. The pediatrics segment, by age group, emerged as the leading revenue component due to intense focus on early childhood immunizations and nationwide campaigns to prevent the spread of infectious diseases.

Furthermore, the tuberculosis application segment dominates the market, staying in line with the global initiative to curb the disease’s prevalence. However, the bladder cancer segment manifests rapid growth, recognizing the BCG vaccine’s proven efficacy in preventing and treating this type of cancer.

By distribution channel, hospitals continue to lead given their pivotal role in organizing and administering vaccines. Clinics and other channels are expected to grow rapidly as they play an increasingly important role in local healthcare delivery systems.

From a regional perspective, North America holds the largest revenue share thanks to its well-structured healthcare system and effective immunization programs. The Asia Pacific region promises the fastest growth rate due to its burgeoning population, heightened health awareness, and aggressive vaccination strategies.

This new report offers an exhaustive analysis of the BCG vaccine market with data segmented by age group, application, and distribution channel. Regional insights spanning North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa further augment the report’s robustness, providing a vital tool for stakeholders in the healthcare and pharmaceutical sectors.

Market players and investors will find the report’s company profiles section particularly valuable as it showcases strategic developments among the top market participants. With its comprehensive data and insights, the report serves as an indispensable resource for anyone looking to understand the landscape and dynamics of the global BCG vaccine market.

  • BCG Vaccine Market Analysis & Forecast by Age Group 2023 – 2034 (Revenue USD Mn)
  • BCG Vaccine Market Analysis & Forecast by Application 2023 – 2034 (Revenue USD Mn)
    • Tuberculosis
    • Bladder Cancer
  • BCG Vaccine Market Analysis & Forecast by Distribution Channel 2023 – 2034 (Revenue USD Mn)
  • BCG Vaccine Market Analysis & Forecast by Region 2023 – 2034 (Revenue USD Mn)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Companies Mentioned
    • Merck & Co. Inc. (Merck)
    • Sanofi Pasteur
    • Japan BCG Laboratory S.A.
    • Statens Serum Institut
    • Serum Institute of India
    • InterVax Ltd.
    • China National Pharmaceutical Group Corporation (Sinopharm)
    • GlaxoSmithKline plc (GSK)
    • GreenSignal Bio Pharma Limited
    • SII Biologicals (formerly Bilthoven Biologicals)
    • Immunotec Inc.
    • Thermo Fisher Scientific Inc.
    • Biofabri
    • AJ Vaccines
    • Merlion Pharmaceuticals GmbH

Key Attributes

Report Attribute Details
No. of Pages 200
Forecast Period 2023-2034
Estimated Market Value (USD) in 2023 $104.6 Million
Forecasted Market Value (USD) by 2034 $187.9 Million
Compound Annual Growth Rate 5.4%
Regions Covered Global

For more information about this report visit https://www.researchandmarkets.com/r/rlygai

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global BCG Vaccine Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

GeeFi’s (GEE) Presale Reports Strong Momentum With 80% of Phase 2 Already Sold Out

GeeFi (GEE) Announces Upcoming DEX Focused on Smarter and User-Centric Trading

EVDANCE Expands 2025 Home Charging Guidance with In-Depth Recommendations for Certified Level-1 and Level-2 Portable EV Chargers

Ethereum-Based Mutuum Finance (MUTM) Confirms Ongoing Halborn Security Reviews Ahead of V1 Launch

Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods

LipoVive Releases Updated Gelatin Trick Guide as Pre-Meal Satiety Strategies Gain Momentum

DeFi Crypto Mutuum Finance (MUTM) Advances Through Roadmap Phase 2 with Over $19M in Funding

New Crypto Mutuum Finance (MUTM) Reports Phase 6 98% Allocation and Core Protocol Development Ahead of Q4 V1

Pollock Company Acquires ATG Communications, Strengthening Local Technology Infrastructure

Editors Picks

GeeFi’s (GEE) Presale Reports Strong Momentum With 80% of Phase 2 Already Sold Out

December 14, 2025

I’m finally beginning to trust Microsoft’s handheld Xbox Allys

December 14, 2025

Evacuation alerts in Abbotsford, B.C. rescinded as floodwaters recede

December 14, 2025

GeeFi (GEE) Announces Upcoming DEX Focused on Smarter and User-Centric Trading

December 14, 2025

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Inside the high drama of the iPhone 4

December 14, 2025

EVDANCE Expands 2025 Home Charging Guidance with In-Depth Recommendations for Certified Level-1 and Level-2 Portable EV Chargers

December 14, 2025

The end of OpenAI, and other 2026 tech predictions

December 14, 2025
Facebook X (Twitter) Pinterest TikTok Instagram
© 2025 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version